The content on this site is intended for healthcare professionals only
Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin i...
Prof Benoit You - Hospices Civils de Lyon, Lyon, France
14 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
13 Apr 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Feb 2022
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Fr...
19 Jan 2022
Latest in advanced endometrial cancer
Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace ...
9 Dec 2021
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
8 Dec 2021
The Lancet Commission on women and cancer
Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg ...
3 Dec 2021
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
18 Oct 2021
Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve ef...
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
24 Sep 2021
Drug combination shows promise in treatment-resistant advanced ovarian cancer
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
24 Sep 2021
ESMO 2021 Roundup
Dr Bishal Gyawali - Queen's University, Kingston, Canada
22 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 3
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Sep 2021